0000014272-18-000131.txt : 20180622 0000014272-18-000131.hdr.sgml : 20180622 20180622192052 ACCESSION NUMBER: 0000014272-18-000131 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180622 DATE AS OF CHANGE: 20180622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dubow Adam CENTRAL INDEX KEY: 0001744507 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 18915659 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: RT 206 & PROVINCE LINE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 3 1 wf-form3_152970963409049.xml FORM 3 X0206 3 2018-06-14 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001744507 Dubow Adam BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 Chief Compliance & Ethics Offi Common Stock, $0.10 par value 14698.152 D Common Stock, $0.10 par value 886.9731 I By BMY Savings and Investment Program Market Share Units 2019-03-10 Common Stock, $0.10 par value 304.0 D Market Share Units 2020-03-10 Common Stock, $0.10 par value 741.0 D Market Share Units 2021-03-10 Common Stock, $0.10 par value 1354.0 D Market Share Units 2022-03-10 Common Stock, $0.10 par value 1663.0 D Performance Shares 2019-03-10 Common Stock, $0.10 par value 2218.0 D Performance Shares 2020-03-10 Common Stock, $0.10 par value 2707.0 D Performance Shares 2021-03-10 Common Stock, $0.10 par value 2495.0 D Restricted Stock Units 2018-09-03 Common Stock, $0.10 par value 797.0 D Based on plan statement as of most recent fiscal quarter. These market share units will vest on March 10, 2019. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. One-half of these market share units will vest on each of March 10, 2019 and March 10, 2020. One-third of these market share units will vest on each of March 10, 2019, March 10, 2020, and March 10, 2021. Twenty-five percent of these market share units will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 10, 2019. Each performance share converts into one share of common stock upon distribution in the first quarter of 2019, subject to a Total Shareholder Return modifier. Each performance share converts into one share of common stock upon distribution in the first quarter of 2020. Each performance share converts into one share of common stock upon distribution in the first quarter of 2021. These restricted stock units will vest on September 3, 2018. Each restricted stock unit converts into one share of common stock upon vesting. EXHIBIT LIST: EX-24 Adam Dubow Power of Attorney /s/ Lisa A. Atkins, attorney-in-fact for Adam Dubow 2018-06-22 EX-24 2 ex-24.htm EXHIBIT 24 - ADAM DUBOW POWER OF ATTORNEY

POWER OF ATTORNEY

    I, Adam Dubow, Chief Compliance and Ethics Officer of Bristol-Myers Squibb Company (the "Company"), a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung, Katherine R. Kelly, Yun Jung Choi and Lisa A. Atkins, individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934 with respect to securities issued by the Company, including, without limitation, the execution and filing of a Form ID and all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions.  This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4, and 5 with respect to securities issued by the Company, unless earlier revoked.

    IN WITNESS WHEREOF, I have executed this Power of Attorney on this 20 day of June, 2018.



/s/Adam Dubow
Adam Dubow